Filing Flows › ELI Lilly (LLY) › Recalls, complaints & regulation
ELI Lilly (LLY): recalls, EPA violations, clinical trials and Federal Register
ELI Lilly (LLY) beyond its filings: 0 recalls in the last 12 months (1 in five years, 0 Class I); 2 EPA-regulated facilities in violation, no penalties in five years; 20 Federal Register documents in a year; 234 active clinical trials.
Latest recalls
- 2024-04-24 · FDA drug · Sterile Diluent, HUMALOG U-100 (insulin lispro injection), HUMULIN R U-100 REGULAR (insulin human injection), Insulin Lispro Injection u-100, 10 mL, Use ONLY wi
EPA facilities in violation
| Facility (as registered) | City | Status | Penalties |
|---|---|---|---|
| ELI LILLY & CO LILLY TECH CTR | Indianapolis, IN | Violation Identified | — |
| ELI LILLY AND COMPANY - LEBANON FACILITY | Lebanon, IN | Violation Identified | — |
Facilities in the EPA's ECHO register whose registered name matches the company's; a facility can belong to another business of the same name.
ELI Lilly's latest quarter
ELI Lilly, Q3 2026: revenue $24.4B (+39% year over year), operating margin 34.5%, net earnings $6.5B, operating cash flow $11.4B. The chart follows the revenue to costs, profit and cash.
Questions
Has ELI Lilly had any recalls?
1 recall on file over five years from the FDA, CPSC and NHTSA; 0 in the last 12 months.
Has ELI Lilly been fined by the EPA?
The 56 EPA-regulated facilities on file under its name drew no penalties in five years; 2 are in violation now.
How many clinical trials does ELI Lilly have?
234 active studies on ClinicalTrials.gov, 94 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.